| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| META | Communication Services | Arete | Upgrade | Neutral → Buy | $735 | $1.5T | $600.47 | +0.5% | -0.5% | +4.2% | +0.7% | -5.5% | -1.3% |
| TMO | Healthcare | Wolfe Research | Reiterates | Outperform | $535 | $183.6B | $494.04 | -0.9% | -2.4% | -1.7% | +1.7% | -1.9% | -0.7% |
| DHR | Healthcare | Wolfe Research | Reiterates | Peer Perform | — | $127.3B | $179.87 | -1.2% | -2.1% | +1.1% | +4.8% | -1.3% | -0.4% |
| INTU | Technology | Goldman | Downgrade | Neutral → Sell | $276 | $96.8B | $353.76 | -6.8% | -8.9% | -3.3% | -3.0% | -1.7% | +2.9% |
| SHW | Basic Materials | UBS | Downgrade | Buy → Neutral | $330 | $72.7B | $294.86 | -1.0% | -0.6% | +1.2% | +1.2% | +1.7% | -1.9% |
| CRWV | Technology | BNP Paribas Exane | Initiates | Outperform | $192 | $68.1B | $124.82 | +4.1% | -4.4% | -7.0% | -2.6% | -7.1% | +2.0% |
| NBIS | Communication Services | BNP Paribas Exane | Initiates | Neutral | $255 | $63.5B | $264.51 | +2.9% | -1.5% | -3.4% | +3.2% | -12.3% | -4.3% |
| NU | Financial Services | BofA Securities | Downgrade | Neutral → Underperform | $10 | $62.9B | $12.99 | -7.7% | -8.2% | -2.4% | +4.1% | -1.2% | -3.1% |
| HPE | Technology | Loop CapitalB | Upgrade | Hold → Buy | $75 | $62.4B | $47.00 | +34.2% | +19.5% | -1.8% | -2.6% | -8.4% | +1.4% |
| TTWO | Communication Services | Piper Sandler | Initiates | Overweight | $280 | $42.1B | $226.98 | -2.1% | -2.0% | -3.0% | +0.4% | -1.0% | -0.9% |
| ED | Utilities | Mizuho | Downgrade | Outperform → Neutral | $105 | $38.2B | $103.60 | -0.7% | +0.2% | -0.3% | +0.6% | +2.1% | -1.8% |
| VMC | Basic Materials | Berenberg | Initiates | Hold | $283 | $36.5B | $281.56 | -1.1% | +0.1% | +1.2% | -0.8% | -0.6% | -4.1% |
| MLM | Basic Materials | Berenberg | Initiates | Hold | $556 | $34.3B | $570.96 | -0.9% | +1.0% | +1.1% | -0.4% | -0.9% | -3.8% |
| NTRA | Healthcare | Wolfe Research | Reiterates | Outperform | $260 | $31.3B | $218.81 | -1.8% | -2.8% | -0.4% | +4.8% | -3.1% | -0.9% |
| WAT | Healthcare | Wolfe Research | Reiterates | Outperform | $425 | $24.6B | $378.16 | -1.5% | -1.6% | +2.1% | -0.9% | -3.0% | -0.6% |
| MTD | Healthcare | Wolfe Research | Reiterates | Peer Perform | — | $23.9B | $1183.57 | -1.3% | -1.1% | -0.1% | +1.0% | -2.2% | -1.3% |
| SQM | Basic Materials | JP Morgan | Downgrade | Overweight → Neutral | $100 | $23.8B | $83.42 | -2.4% | -3.1% | -2.8% | -1.1% | -2.9% | -3.5% |
| OKTA | Technology | Mizuho | Downgrade | Outperform → Neutral | $125 | $23.4B | $139.79 | -7.0% | -3.2% | -7.9% | -0.9% | -3.9% | -1.6% |
| WST | Healthcare | Wolfe Research | Reiterates | Outperform | $375 | $22.3B | $316.30 | -0.7% | -1.3% | +1.3% | +0.3% | -0.9% | +1.7% |
| GH | Healthcare | Wolfe Research | Reiterates | Outperform | $150 | $17.1B | $129.14 | +2.1% | +0.8% | -2.4% | +4.7% | -5.6% | -0.6% |